Johnson & Johnson

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Johnson & Johnson 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About JNJ

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. 

CEO
Joaquin Duato
CEOJoaquin Duato
Employees
139,800
Employees139,800
Headquarters
New Brunswick, New Jersey
HeadquartersNew Brunswick, New Jersey
Founded
1887
Founded1887
Employees
139,800
Employees139,800

JNJ Key Statistics

Market cap
493.38B
Market cap493.38B
Price-Earnings ratio
19.72
Price-Earnings ratio19.72
Dividend yield
2.52%
Dividend yield2.52%
Average volume
5.62M
Average volume5.62M
High today
$205.00
High today$205.00
Low today
$205.00
Low today$205.00
Open price
$204.49
Open price$204.49
Volume
258.09K
Volume258.09K
52 Week high
$215.19
52 Week high$215.19
52 Week low
$140.68
52 Week low$140.68

Stock Snapshot

As of today, Johnson & Johnson(JNJ) shares are valued at $205.00. The company's market cap stands at 493.38B, with a P/E ratio of 19.72 and a dividend yield of 2.5%.

On 2026-01-07, Johnson & Johnson(JNJ) stock traded between a low of $205.00 and a high of $205.00. Shares are currently priced at $205.00, which is 0.0% above the low and 0.0% below the high.

Johnson & Johnson(JNJ) shares are trading with a volume of 258.09K, against a daily average of 5.62M.

During the past year, Johnson & Johnson(JNJ) stock moved between $140.68 at its lowest and $215.19 at its peak.

During the past year, Johnson & Johnson(JNJ) stock moved between $140.68 at its lowest and $215.19 at its peak.

JNJ News

TipRanks 25m
Johnson & Johnson submits Ottava Robotic Surgical System to the FDA

Johnson & Johnson announced that the company has submitted the Ottava Robotic Surgical System to the FDA in an application for De Novo classification. Leveragin...

Simply Wall St 3h
Has Johnson & Johnson Run Too Far After Its 44.3% One-Year Surge?

Wondering if Johnson & Johnson is still a solid price for a long-term holding or if the recent run has moved it too far, too fast? This article focuses squarely...

Has Johnson & Johnson Run Too Far After Its 44.3% One-Year Surge?
The Motley Fool 5h
The Smartest Dividend Stocks to Buy With $3,000 Right Now

It's not too late to reshape and optimize your portfolio for what could be a very different market environment than last year's. Do you have some idle cash you...

The Smartest Dividend Stocks to Buy With $3,000 Right Now

Analyst ratings

56%

of 27 ratings
Buy
55.6%
Hold
40.7%
Sell
3.7%

More JNJ News

Investor's Business Daily 24h
Alumis Stock Catapults More Than 100% As Biotech Takes On J&J, Protagonist In Psoriasis

Technology Alumis Stock Catapults More Than 100% As Biotech Takes On J&J, Protagonist In Psoriasis Licensing Biotech stock Alumis (ALMS) catapulted on Tuesday a...

Alumis Stock Catapults More Than 100% As Biotech Takes On J&J, Protagonist In Psoriasis
Seeking Alpha 24h
J&J succeeds in mid-stage trial for SLE therapy

Johnson & Johnson (JNJ) announced on Tuesday that nipocalimab, its experimental therapy for an autoimmune condition called systemic lupus erythematosus, reached...

J&J succeeds in mid-stage trial for SLE therapy
Nasdaq 2d
Dow Movers: JNJ, CVX

In early trading on Monday, shares of Chevron topped the list of the day's best performing Dow Jones Industrial Average components, trading up 4.4%. Year to dat...

Dow Movers: JNJ, CVX
Nasdaq 4d
Dividend Growers: 3 Stocks That Could Be Worth $1 Million in 36 Years.

Key Points NextEra Energy has grown its dividend at a 10% compound annual rate over the past 20 years. Realty Income has increased its dividend for more than...

Dividend Growers: 3 Stocks That Could Be Worth $1 Million in 36 Years.
The Motley Fool 6d
Want Decades of Passive Income? 2 Stocks to Buy Right Now

These income stocks could be great buys to add to your portfolio. Market downturns are inevitable. Accepting this fact can help you avoid making fear-based dec...

Want Decades of Passive Income? 2 Stocks to Buy Right Now
Nasdaq 7d
Interesting JNJ Put And Call Options For February 2026

Investors in Johnson & Johnson (Symbol: JNJ) saw new options begin trading today, for the February 2026 expiration. At Stock Options Channel , our YieldBoost fo...

Interesting JNJ Put And Call Options For February 2026

People also own

Based on the portfolios of people who own JNJ. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.